Evoxac and Lansoprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Evoxac (cevimeline hydrochloride) and Lansoprazole (lansoprazole). Common drug interactions include toxic epidermal necrolysis among females and back injury among males.

The phase IV clinical study analyzes what interactions people have when they take Evoxac and Lansoprazole. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Evoxac?

Evoxac has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 2,028 Evoxac users. Check the latest studies of Evoxac.

What is Lansoprazole?

Lansoprazole has active ingredients of lansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 129,663 Lansoprazole users. Check the latest studies of Lansoprazole.



On Jul, 13, 2026

38 people who take Evoxac and Lansoprazole together, and have interactions are studied.

Evoxac and Lansoprazole drug interactions.

What are the common drug interactions of Evoxac and Lansoprazole, by gender? *:

female:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Ulnar nerve palsy
  3. Urinary tract infection
  4. Urine output decreased
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Dyspnoea (difficult or laboured respiration)
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  8. Cardiomegaly (increased size of heart than normal)
  9. Arthralgia (joint pain)
  10. Iron deficiency anaemia

male:

  1. Back injury
  2. Anaemia (lack of blood)
  3. Nausea (feeling of having an urge to vomit)
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. Pyrexia (fever)
  6. Viral upper respiratory tract infection
  7. Chest pain
  8. Decreased appetite
  9. Dizziness
  10. Dyspnoea exertional (breathlessness or shortness of breath)

What are the common drug interactions of Evoxac and Lansoprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Iron deficiency anaemia
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Blood creatine phosphokinase increased
  4. Gastroenteritis (inflammation of stomach and intestine)
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  7. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  8. Osteonecrosis (death of bone)
  9. Otitis externa (external ear infection)
  10. Purpura (purplish discoloration of the skin)

30-39:

  1. Platelet count decreased

40-49:

n/a

50-59:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Extranodal marginal zone b-cell lymphoma (malt type) (cancer originating from b cells in the marginal zone of the malt)
  3. Flushing (the warm, red condition of human skin)
  4. Nausea (feeling of having an urge to vomit)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Palpitations (feelings or sensations that your heart is pounding or racing)
  7. Pneumonia
  8. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  9. Pyrexia (fever)
  10. Rash

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  3. Application site pruritus (application site severe itching of the skin)
  4. Application site rash
  5. Aspartate aminotransferase increased
  6. Blood sodium decreased
  7. Cardiomyopathy (weakening of the heart muscle)
  8. Chest pain
  9. Chronic kidney disease
  10. Confusional state

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 36.84%
  2. Hiv Infection: 6 people, 15.79%
  3. Pain: 5 people, 13.16%
  4. Multiple Myeloma (cancer of the plasma cells): 4 people, 10.53%
  5. High Blood Pressure: 4 people, 10.53%
  6. Pneumonia: 3 people, 7.89%
  7. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 3 people, 7.89%
  8. High Blood Cholesterol: 3 people, 7.89%
  9. Dry Mouth: 3 people, 7.89%
  10. Gastric Disorder (disease of stomach): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Evoxac and Lansoprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Evoxac and Lansoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Evoxac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lansoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evoxac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lansoprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cevimeline hydrochloride and lansoprazole (the active ingredients of Evoxac and Lansoprazole, respectively), and Evoxac and Lansoprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: